The Newsmakers

April 16, 2024

DENVER, Colo., Apr 16, 2024 (247marketnews.com)- This morning’s notable listings with recent news include ParaZero Technologies Ltd. (Nasdaq:PRZO), Treasure & Shipwreck Recovery (OTCPK:BLIS), SMX (Security Matters) PLC (NASDAQ:SMX), and Jaguar Health, Inc. (NASDAQ:JAGX).

ParaZero Technologies Ltd. (Nasdaq:PRZO) reminds the world that it recently announced that it intends to enter the counter unmanned aircraft system market.

“Our drone technology solutions leverage a distinct technology portfolio protected by global patents, that we have developed over the course of more than ten years. We believe that this technology portfolio enables us to effectively counteract various threats posed by drones by rapidly developing bespoke C-UAS solutions for key clientele,” stated Boaz Shetzer, ParaZero CEO. “Recent international conflicts have highlighted the extensive use of drones in various attacks and the critical necessity to counteract these strikes promptly with minimal damage. We have commenced develop of dedicated solutions, based on our technology, and we believe that ParaZero can provide a unique alternative to today’s conventional solutions.”

Treasure & Shipwreck Recovery (OTCPK:BLIS) recently announced that it’s merging with Native American Pride Constructors (“NAPC”), which has the exclusive license to produce and sell the Corner Shot USA System, in the USA and Saudi Arabia, and will manufacture the product at its Florida facility. NAPC signed an LOI to sell Corner Shot units to Saudi Arabia, valued at approximately $370,000,000, with a net profit margin of at least 20% to NAPC.

SMX (Security Matters) PLC (NASDAQ:SMX) successfully completed its roof of concept for ethical sourcing and authentication of silver in cooperation with SMI, marking of 2.2 tons of silver within SMI’s operations.

The program covered the marking of the silver raw material through continuous manufacturing processes to final products including recycling loops, as SMX’s technology was added at the melting stage and the marked silver material was processed into blank and the quality of the marked intermediate material and final products was evaluated.

Jaguar Health, Inc. (NASDAQ:JAGX) reported signing an exclusive 5-year in-license agreement with Venture Life Group PLC, an international consumer health company based in the United Kingdom, for Venture Life’s FDA-approved oral mucositis prescription product, Gelclair, for the U.S. market.

“We are very happy to have executed the in-license agreement for Gelclair – and thus to have initiated Jaguar’s commercial footprint in our core focus area of cancer supportive care,” stated Lisa Conte, Jaguar’s president and CEO. “Oral mucositis is among the most common, painful, and debilitating cancer treatment-related side effects. Gelclair is a protective gel with a mechanical action indicated for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies, including oral mucositis/stomatitis. Unlike other products for oral mucositis, it is not a numbing agent and does not sting the mouth.”

Maged Ghaly, MD, a radiation oncologist at Northwell Health Cancer Institute, Monter Cancer Center, stated, “A key attribute in the management of head and neck cancer patients with Gelclair is, in my experience, to delay the onset which may decrease the severity of oral mucositis, allowing the patients to continue meeting their nutritional needs without having to go on a feeding tube, supporting their ability to withstand their 6 weeks of radiation therapy without having to go to lower doses or treatment interruptions, and to avoid the need for heavy prescription meds for oral mucositis-related pain.”

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (PRZO, BLIS, SMX), JAGX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.